Open Access

Transparent Process

p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylation

Rajan Gogna, Esha Madan, Mahmood Khan, Uttam Pati, Periannan Kuppusamy

Author Affiliations

  1. Rajan Gogna1,,
  2. Esha Madan1,,
  3. Mahmood Khan1,2,
  4. Uttam Pati3 and
  5. Periannan Kuppusamy*,1,4
  1. 1Dorothy M. Davis Heart and Lung Research Institute, Division of Cardiovascular Medicine, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA
  2. 2Department of Emergency Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA
  3. 3Transcription and Human Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India
  4. 4Department of Radiology, Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH, USA
  1. * Corresponding author:
    Tel: +1 603 650 1034; Fax: +1 603 643 0304;
    E‐mail: periannan.kuppusamy{at}
  1. These authors contributed equally to this work.

View Full Text


Myocardial infarction, an irreversible cardiac tissue damage, involves progressive loss of cardiomyocytes due to p53‐mediated apoptosis. Oxygenation is known to promote cardiac survival through activation of NOS3 gene. We hypothesized a dual role for p53, which, depending on oxygenation, can elicit apoptotic death signals or NOS3‐mediated survival signals in the infarct heart. p53 exhibited a differential DNA‐binding, namely, BAX‐p53RE in the infarct heart or NOS3‐p53RE in the oxygenated heart, which was regulated by oxygen‐induced, post‐translational modification of p53. In the infarct heart, p53 was heavily acetylated at Lys118 residue, which was exclusively reversed in the oxygenated heart, apparently regulated by oxygen‐dependent expression of TIP60. The inhibition of Lys118 acetylation promoted the generation of NOS3‐promoting prosurvival form of p53. Thus, oxygenation switches p53‐DNA interaction by regulating p53 core‐domain acetylation, promoting a prosurvival transcription activity of p53. Understanding this novel oxygen‐p53 survival pathway will open new avenues in cardioprotection molecular therapy.

  • Received September 20, 2012.
  • Revision received August 6, 2013.
  • Accepted August 9, 2013.
Creative Commons logo

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

View Full Text